
usd apr pm et
sealant adhes chemic addit
price-to-earnings oper ep
risk assess reflect compani strong
histor earn dividend growth reflect
 gmi qualiti rank lead posit
mani market serv strong balanc sheet
rel low debt level
past perform indic futur perform reli upon
analysi prepar equiti analyst
apr pm stock trade
follow declin see
higher revenu revenu
forecast follow segment industri
safeti graphic electron
energi revenu growth like
affect impact strong dollar
report compani revenu like
benefit recoveri global econom
demand new product
due acquisit organ revenu
project ebitda margin
versu
oper margin four
busi segment health
enjoy margin safeti industri
transport electron
consum lag
view good profit see ebitda
margin aid cost save
see adjust ep
increas expect free cash flow
cash flow oper less capit
expenditur approxim net
hold recommend
share reflect worri slow
tariff trade war initi
restructur aim cut
million annual follow
januari restructur
cut addit million
fourth-quart result wors
expect dividend current yield
provid incom compon
see dividend safe
complet acquisit acel inc
billion octob price
equat report ebitda
thought steep risk
recommend target price includ
slower global econom growth wors
expect acquisit execut failur
continu introduc market new
innov product slower growth
target price
ep estim five-year
averag forward price-to-earnings line industri
fiscal year end dec ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
senior vice-president innov
stewardship
corpor overview co global manufactur oper broadli diversifi busi revenu
total approxim billion classifi busi five report segment --
industri health safeti graphic consum electron product involv
expertis product develop manufactur market mani compani product
involv form coat sealant adhes film chemic addit increas product
overal function usabl consum industri segment revenu
segment oper profit serv broad rang market applianc electron paper
packag food beverag automot automot aftermarket renew energi aerospac
marin transportation-rel industri product includ pressure-sensit tape abras
softwar solut insul compon film mask tape fasten adhes name
safeti graphic segment product includ person protect equip
safeti secur product track trace solut increas safeti secur
product peopl facil system addit busi provid broad portfolio
graphic solut enhanc visual impact inspir creativ commun design
healthcar segment serv market world-wide includ medic surgic
pharmaceut dental health inform system person care varieti medic
surgic suppli infect prevent pharmaceut drug deliveri system dental person care
product system electron segment serv global
electron energi market provid product contribut reliabl sourc power
high-perform electron devic speedi depend telecommun network
busi focus use renew energi sourc improv qualiti reduc cost
consum segment serv market includ consum retail offic retail home
improv build mainten market offer consist offic suppli stationeri
product construct home improv product home care product protect materi etc
primari busi dynam global consum industri technolog innov growth
compani compani focus expand relev custom gain profit market
share acceler market penetr across develop develop market aim
outperform global industri product growth histor acquisit play strong role
portfolio growth expect remain key part overal strategi anticip return
signific amount cash sharehold research product develop constitut import
part activ major driver sale profit growth research develop
relat expens total billion billion billion
billion geograph distribut sale follow asia pacif europ
middl east africa latin america canada compani employ peopl
decemb employ employ intern catalyst
octob acquir acel inc consortium privat fund includ apax partner
canada pension invest board billion includ assumpt debt acel maker
wound care technolog solut kci brand believ good fit
medic solut busi purchas price report ebitda expect price
adjust ebitda first follow purchas acel revenu
billion expect deal dilut ep year one exclud one-tim cost
purchas account adjust accret time period result purchas
financ exist cash issuanc new debt cut forecast
share repurchas billion billion april announc
restructur action result reduct posit world-wide
estim pre-tax save million million million remaind
januari announc restructur would cut job
aim cut cost addit million million
financi trend past ten year exhibit compound annual growth rate cagr
follow revenu ebitda earn per share dividend per share
capit expenditur total billion billion see similar level
spend compani continu invest intern manufactur facil
close align busi function sale mix sale gener outsid long
term debt made total capit year end year earlier well
fourth-quart sale increas fell organ basi
consensu expect adjust ep versu also wors consensu
expect result impact slow condit certain key end market foreign
currenc effect guid full year adjust ep
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu usd
neutral sinc januari technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook industri
conglomer sub-industri next
month neg expect coronaviru
drive global downturn demand
industri product sub-industri
provid aviat product estim
largest revenu categori
sub-industri like especi hard
hit due viruss uniqu impact air
travel product number two
also see signific drop recess
typic bring lower energi consumpt
delay spend new product asset
expect sever pocket out-performance
within sub-industri howev includ
health care product person protect
equip driven virus-induc demand surg
categori
industri conglomer ic alreadi
see weak demand head
coronavirus-induc recess seem like
compound downturn sub-industri revenu
fell despit healthi
growth think due
high tariff environ rais product
cost weaken global trade tip
manufactur contract second
half accord feder reserv
data ic firm larg manufactur
oper sale earn
especi impact high tariff
environ view
march alreadi soft demand
environ got lot wors coronaviru
began shut busi consum
activ across world one
hardest hit area aviat estim
aviation-rel product servic
includ jet engin aircraft
sub-assembl electron compon
compris roughli sub-industri revenu
primari end user product
airlin govern corpor
air travel restrict send
unpreced demand shock
airlin industri expect ic aviat
revenu see signific contract
next year gener electr honeywel
like hardest hit downturn
revenu deriv
global recess like drive lower
demand energi product servic
well reduc revenu ic
wind hydro turbin grid infrastructur
etc gener sub-industri revenu
busi close viru mitig
effort gener lower busi activ
expect prolong period afterward
see signific reduct energi
consumpt year turn expect
lower demand ic product support
product distribut energi
despit gener demand downturn
expect sub-industri exposur
health care product person protect
equip ppe mitig
blow view global spread
coronaviru driven massiv demand
increas health care equip test
develop treatment viru
well ppe mask glove
protect health care worker treat influx
patient major ic ge
honeywel benefit
dynam due exposur health care
technolog product ppe
year date march
versu declin
base index
five-year market price perform apr
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
cut target price ep estim
cut today line three-year averag trim
ep estim adjust ep versu
miss estim consensu revenu declin
larg neg foreign currenc industri electron particularli
weak sale oper incom declin busi unit
initi restructur cut job effort cut cost
mil mil annual take pre-tax charg mil
compani also increas legal reserv two lawsuit lower
adjust ep guidanc versu prior quarter
bad across front also question share buyback
offset stock issuanc howev think good core product long
term profit solid /jim corridor
et cfra keep hold recommend share compani
rais target price
ep estim cut line five-year averag
slightli three-year averag start ep
estim fourth-quart adjust ep versu miss
estim beat consensu revenu declin
better expect organ revenu growth local currenc
versu target guid ep includ
hit pend acquisit modal versu consensu
organ revenu expect prior guidanc
see growth across geographi busi unit find
encourag expect gener cash oper equal
expect net incom see cash posit good share buyback cut
share count last year see similar repurchas year /jim
analyst research note compani news
pm et cfra keep hold opinion share compani
cut target ep
estim cut line peer adjust ep
versu miss estim revenu rose aid
acquisit organ revenu fell slightli
expect ebitda declin well target strength
health care off-set flat consum sale weak safeti
industri well transport electron gaap
result impact litig restructur charg set cut
job new restructur see annual save
million million realiz guid adjust
ep versu consensu think pull
lever off-set weak fundament demand expect weak
persist see near-term catalyst share outperform
 next year /jim corridor
pm et cfra keep hold opinion share compani
cut target price ep
estim lower toward low-end
five-year price-to-earnings rang trim ep estim
adjust ep versu penni target beat
consensu revenu declin less expect
ebit margin declin less anticip result
hurt weak europ asia also soft
second consecut quarter care revenu consum
safeti industri transport electron
guid ep versu consensu
includ dilut ep acel acquisit
guidanc adjust ep
previous see littl catalyst share global market improv
et cfra keep hold opinion share compani
keep target price ep estim
lower toward lower-end five-year price-to-earnings rang
reflect challeng relat slow global demand sever product
type trim ep estim adjust ep
versu met estim beat consensu revenu
declin beat target ebitda margin declin
move combat weak global condit cut manufactur
output restructur action impact ebitda margin revenu
weak global geographi care
revenu consum safeti industri
transport electron howev oper margin remain
busi unit think take appropri step
combat slowdown see near-term catalyst share /jim corridor
et cfra keep hold opinion share compani
cut target price ep
estim cut line averag cut
ep estim announc buy medic
devic maker acel billion includ assumpt debt acel
make wound care surgic applic kci brand
billion revenu purchas price equat ebitda
find extrem steep estim annual adjust ebitda
first follow transact still find
expens adjust basi say deal accret
ep year two deal dilut first year
time slow share repurchas program expect billion
billion see synergi fit medic
solut busi think take time deal pay back
et cfra keep hold opinion share compani
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
redistribut reproduct prohibit without prior written permiss copyright cfra
